ArticleFrontiers in pharmacology2019

The Immune-Modulator Pidotimod Affects the Metabolic Profile of Exhaled Breath Condensate in Bronchiectatic Patients: A Metabolomics Pilot Study.

Maria D'Amato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.